SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
SciSparc's majority-owned subsidiary NeuroThera Labs completed a non-brokered private placement raising aggregate gross proceeds of C$5.4 million. SciSparc participated with a C$2.7 million investment, representing half of the total raise, and will hold approximately 44.6% of NeuroThera's issued and outstanding shares.
Key figures
- Ownership percent
- 44.6%
- Price per unit cad
- 0.12
- Stake valuation cad
- C$30 million
- Financing proceeds cad
- C$5.4 million
- Scisparc investment cad
- C$2.7 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.